Abstract | OBJECTIVE: METHODS: RESULTS: The cerebral circulatory parameters in hypertensive patients before treatment with Amlodipine were different from those in healthy persons. Amlodipine along with the reduction in systemic blood pressure caused attenuation of cerebrovascular abnormalities: decrease in spastic signs and increase in cerebral blood supply in patients with essential hypertension. CONCLUSION:
Amlodipine causes reduction of cerebral vascular resistance and promotes improvement in arterial blood filling in patients with essential hypertension. These changes in cerebral circulation may be secondary to the increase of cardiac output--known effect of Amlodipine.
|
Authors | I G Alizade, N T Karayeva |
Journal | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology
(Anadolu Kardiyol Derg)
Vol. 1
Issue 1
Pg. 14-6
(Mar 2001)
ISSN: 1302-8723 [Print] Turkey |
PMID | 12122965
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Calcium Channel Blockers
- Amlodipine
|
Topics |
- Adult
- Amlodipine
(pharmacology, therapeutic use)
- Blood Pressure
(drug effects)
- Calcium Channel Blockers
(pharmacology, therapeutic use)
- Case-Control Studies
- Cerebral Arteries
(drug effects, physiology)
- Cerebrovascular Circulation
(drug effects)
- Female
- Humans
- Hypertension
(drug therapy, physiopathology)
- Male
- Middle Aged
- Plethysmography, Impedance
- Treatment Outcome
|